Immediate Impact
2 by Nobel laureates 3 from Science/Nature 70 standout
Citing Papers
Lorlatinib Versus Crizotinib in Patients With Advanced ALK -Positive Non–Small Cell Lung Cancer: 5-Year Outcomes From the Phase III CROWN Study
2024 Standout
New promises and challenges in the treatment of advanced non-small-cell lung cancer
2024 Standout
Works of Chris McKenna being referenced
Immune-Modified Response Evaluation Criteria In Solid Tumors (imRECIST): Refining Guidelines to Assess the Clinical Benefit of Cancer Immunotherapy
2018
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Chris McKenna | 290 | 115 | 23 | 190 | 38 | 716 | |
| Ying Zhang | 106 | 85 | 7 | 46 | 61 | 631 | |
| Patricia A. Robinson | 106 | 113 | 8 | 201 | 31 | 841 | |
| Fred H. Goldner | 31 | 48 | 19 | 93 | 35 | 775 | |
| Patrik Hesselius | 44 | 100 | 4 | 237 | 38 | 715 | |
| Neil McHugh | 163 | 135 | 26 | 41 | 49 | 845 | |
| Jing Li | 119 | 21 | 12 | 165 | 50 | 671 | |
| Valérie Durieux | 60 | 33 | 11 | 126 | 29 | 804 | |
| Patrick P. McHugh | 20 | 58 | 1 | 64 | 40 | 771 | |
| Michael Atkinson | 148 | 104 | 13 | 43 | 43 | 640 | |
| Emre Yücel | 49 | 28 | 3 | 150 | 42 | 666 |
All Works
Loading papers...